Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Monitoring protocols should address both the primary indication (diabetes or weight management) and potential hepatic effects, particularly in patients with known or suspected NAFLD
M (2005)
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
The majority of current users have a primary diagnosis of type 2 diabetes, while a growing proportion are using these medications primarily for weight management
US$ 28.92
US$ 27.09
US$ 21.52
US$ 25.15
US$ 20.26
US$ 21.65
US$ 27.76
US$ 27.81
US$ 23.50
US$ 21.90
